A novel bispecific T-cell engager using the ligand-target csGRP78 against acute myeloid leukemia
Xiaozhu Zeng(Sichuan University), Xudong Zhao(Kunming Institute of Zoology)
Cited by 5
Related Papers
HUWE1 controls the development of non-small cell lung cancer through down-regulation of p53
|Theranostics|2018|81
CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A
|Oncogene|2017|66
Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models
|Translational Oncology|2023|22
Mesothelin-based CAR-T cells exhibit potent antitumor activity against ovarian cancer
|Journal of Translational Medicine|2024|11
Cell-Surface GRP78-Targeted Chimeric Antigen Receptor T Cells Eliminate Lung Cancer Tumor Xenografts
|International Journal of Molecular Sciences|2024|10